Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.16 (
calcineurin
)
17,112
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
gCap39
is an actin filament end-capping protein which is a member of the gelsolin family. Unlike gelsolin,
gCap39
does not sever actin filaments and is a cytoplasmic as well as nuclear protein. We report here that
gCap39
is phosphorylated, while gelsolin is not.
gCap39
is phosphorylated on serines and threonines at multiple sites, and phospho-
gCap39
is resolved by isofocusing into multiple isoforms which are more acidic than unphosphorylated
gCap39
. In vitro dephosphorylation eliminates the acidic isoforms. Okadaic acid, a
protein phosphatase
inhibitor, stimulates
gCap39
phosphorylation in vivo. It preferentially increases labeling of several peptides and enhances labeling of phosphothreonines relative to phosphoserines. The phosphorylation state of
gCap39
in cells is therefore regulated by a balance between kinases and okadaic acid-sensitive phosphatases, and phosphorylation sites containing threonines appear to be particularly sensitive to the phosphatases. Subcellular fractionation shows that the nuclear fraction contains 17 +/- 5% (n = 3) of total
gCap39
. Compared with the soluble cytoplasm, nuclear
gCap39
has a 1.7 +/- 0.2 (n = 3) fold increase in the amount of 32P label incorporation and a higher ratio of acidic/basic
gCap39
. We conclude that phospho-
gCap39
is preferentially associated with nuclei and suggest that phosphorylation of
gCap39
is functionally significant.
...
PMID:gCap39 is phosphorylated. Stimulation by okadaic acid and preferential association with nuclei. 838 92